-
JOC_2009_271_R_0005_02
Non-opposition to a notified concentration (Case COMP/M.5555 — Novartis/Ebewe) Text with EEA relevance
OJ C 271, 12.11.2009, p. 5–5 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52009XC1030(02)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 May 2009 to 31 May 2009 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC )
OJ C 260, 30.10.2009, p. 15–30 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
52009XC1030(01)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 September 2009 to 30 September 2009 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council )
OJ C 260, 30.10.2009, p. 6–14 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62007A0326C(01)
Case T-326/07: Judgment of the Court of First Instance of 3 September 2009 — Cheminova and Others v Commission (Plant-protection products — Active substance malathion — Non-inclusion in Annex I to Directive 91/414/EEC — Action for annulment — Locus standi — Admissibility — Evaluation procedure — Assessment by EFSA — Plea of illegality — Article 20 of Regulation (EC) No 1490/2002 — Submission of new studies — Article 8(2) and (5) of Regulation (EC) No 451/2000 — Legitimate expectation — Proportionality — Equal treatment — Principle of sound administration — Rights of the defence — Principle of subsidiarity — Article 95(3) EC, Articles 4(1) and 5(1) of Directive 91/414)
OJ C 256, 24.10.2009, p. 24–25 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62009P0355C(01)
Case C-355/09: Action brought on 3 September 2009 — Commission of the European Communities v Ireland
OJ C 256, 24.10.2009, p. 16–16 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62007J0482C(01)
Case C-482/07: Judgment of the Court (Third Chamber) of 3 September 2009 (Reference for a preliminary ruling from the Rechtbank te ’s-Gravenhage (Netherlands)) — AHP Manufacturing BV v Bureau voor de Industriële Eigendom (Patent law — Proprietary medicinal products — Regulations (EEC) No 1768/92 and (EC) No 1610/96 — Supplementary protection certificate for medicinal products — Conditions for granting certificates to two or more holders of basic patents for the same product — Clarification on the existence of pending applications)
OJ C 256, 24.10.2009, p. 3–4 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
32002L0037R(01)
This corrigendum does not concern the English version.
-
C2009/246/04
Non-opposition to a notified concentration (Case COMP/M.5530 — Glaxo Smith Kline/Stiefel Laboratories) Text with EEA relevance
OJ C 246, 14.10.2009, p. 6–6 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62009H0290C(01)
Case T-290/09: Action brought on 24 July 2009 — Omnicare v OHIM — Astellas Pharma (formerly Yamanouchi Pharma) (OMNICARE)
OJ C 244, 10.10.2009, p. 7–8 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62009H0289C(01)
Case T-289/09: Action brought on 24 July 2009 — Omnicare v OHIM — Astellas Pharma (formerly Yamanouchi Pharma) (OMNICARE CLINICAL RESEARCH)
OJ C 244, 10.10.2009, p. 7–7 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|